Health & Happiness Group (H&H Group) says demand for its high-end adult nutrition brand Swisse Plus+, especially its nicotinamide adenine dinucleotide (NAD+) and liver health products, is key to the 37.4 per cent revenue jump for its adult nutrition...
From India's anti-hangover brand Morning Fresh's new product development plans to H&H Group adopting the 'rotating CEO' model, and new research findings on COVID-19 and nutritional interventions, here are the most-read stories...
Swisse and Biostime’s parent firm Health and Happiness Group (H&H Group) is adopting a ‘rotating CEO’ model after its most recent leader stepped down following a 2.5-month stint to pursue ‘other personal and professional interests’.
Demand for paediatric probiotics and nutritional supplements in mainland China declined in Q3, as parents were shopping less in pharmacies for immunity related products, according to Hong Kong-headquartered Health and Happiness Group (H&H Group).
The paediatric probiotics business has helped to offset a revenue slump in the infant formula business in China for Health and Happiness Group (H&H Group), while its adult nutrition portfolio surged by 55 per cent.
From H&H Group's appointment of a new CEO to South Korea's nutraceutical industry trends and developments, here are the most-read stories in June 2023.
Biostime’s newly approved infant formulas in China are using osteopontin from bovine milk, also known as lactopontin (LPN), as one of the key ingredients, said parent firm Health and Happiness Group (H&H Group).
Health and Happiness Group (H&H Group) has appointed a former Coty, Reckitt Benckiser exec as its new CEO, while its flagship nutra brand Swisse has smashed the $1bn sales barrier.
Swisse says that the sales of its vitamin and mineral supplement products are growing faster than the market rate in key markets such as China, Australia and New Zealand, and that it is expecting more room for growth in South East Asia.
Here we summed up the 10 most watched health and nutrition news videos of the year, including Fonterra’s cultured milk drink launch in Singapore, Vinamilk’s and Health and Happiness Group’s analysis of Vietnam’s infant formula market and more.
Health and Happiness Group (H&H Group)’s new product development priorities, Nestle launching infant formulas containing a novel nutrient blend and human milk oligosaccharides (HMOs), and Danone’s healthy ageing products are some of the most popular...
The gut-organ axis is a key innovation opportunity for probiotics, according to Health and Happiness Group (H&H Group) – the company behind health supplement brand Swisse and infant nutrition products Biostime.
Swisse has launched its first set of sports nutrition products designed for the general public’s active lifestyle needs – a move that it sees as expanding the category largely catered to elite athletes.
Health and Happiness Group (H&H Group) says supplement brand Swisse and pet nutrition brands Solid Gold, Zesty Paws were the key contributors of its revenue growth in the first nine months of this year.
Key players in China’s infant formula industry have reported a drop in their gross profit margins in the first six months of this year, including the biggest local player Feihe, as well as Health and Happiness Group (H&H Group), and Ausnutria.
Human milk oligosaccharide (HMO) is one of the hottest and most commonly seen ingredients in Vietnam’s infant formula products these days, according to Vietnam homegrown firm Vinamilk and Hong Kong-headquarted Health & Happiness Group (H&H Group),...
Swisse said growth momentum in China remained strong, with the brand reporting strong double-digit growth and an offline reach of about 57,000 stores as of Q1 this year.
Swisse has recently entered the Sri Lankan market, highlighting that it is “a market that has always punched above its weight”, despite the country facing one of its worst economic and political crises.
Here we feature the latest exclusive trends insights from major dietary supplement firms, including BYHEALTH’s observations in China, immunity developments in Japan from Kirin, plus key NPD areas from Swisse’s parent company H&H.
Major nutrition company Health and Happiness (H&H Group) is pioneering research on how the right pairings of human milk oligosaccharides (HMOs) and probiotics – a novel category known as ‘HMObiotics’ – could bring about health benefits for consumers...
Swisse’s double digital growth in mainland China and growing business in APAC have cushioned parent company Health and Happiness Group (H&H Group) from a challenging baby nutrition market.
Health and Happiness Group (H&H Group), the parent company of Swisse and Biostime, has reported slowing sales of probiotics in China, although growth remained robust in its infant formula and adult nutrition businesses in the first nine month of this...
Health and Happiness (H&H) Group said offline expansion in China, including introducing its infant formulas to more mother-and-baby stores, as well as the launch of more blue-hat certified health foods in offline trade, has pushed up its revenue for...
H&H has launched Australia’s first kids supplement containing human milk oligosaccharides (HMO), on the back of the ingredient receiving the required regulatory approval earlier this year.
Hong Kong-listed nutrition giant Health and Happiness (H&H) has reported mixed Q1 results, with strong year-on-year sales growth in infant milk formula failing to offset a decline in immunity-related products and probiotics.
Nutrition giant H&H has said it will continue to develop more plant-based products for its dietary supplements and infant formula categories across different brands, with the firm believing consumers are increasingly looking for more sustainable solutions.
H&H Group is pushing for the use of sustainable packaging, including recyclable, renewable, compostable materials, across its brands, including Swisse, Good Goût, CBII and its infant formula range.
In this round-up, we shine the spotlight on nutra trends analysis and forecast from major brands GNC, Nestle, as well as new product development from BY-HEALTH, FANCL, and more.
Tackling allergies, improving digestion and aiding immunity are the key pillars for infant nutrition product innovation, says a group of expert panellists from major brand names such as Biostime, Morinaga, and Nuchev.
This round-up looks at Amway's social commerce, big data ambitions for its health and nutrition business in APAC, H&H's and Blackmores' latest financial updates and more.
Swisse and Biostime owner Health and Happiness (H&H) Group saw demand for immunity products surge, especially in China, as it announced an 8.9% increase in net profit in the first half of this year, despite seeing revenues in Australia and New Zealand...
In this round-up, we feature the latest health and nutrition industry developments in China, including Herbalife strategies in coping with COVID-19 disruption, H&H CEO talks about baby nutrition boom and more.
The CEO of Health and Happiness (H&H) Group has revealed how its baby nutrition products are booming in China and further afield, underlined Swisse’s ambitious international expansion plans, but acknowledged there were some supply chain risks amid...
This round up provides a glimpse on how direct-selling firms in China are adopting new retail models, how H&H plans to expand its kids nutrition portfolio, the impact of the Covid-19 on businesses, and GNC’s blue-hat products.
Health & Happiness (H&H) Group’s Good Gout is focusing on its China expansion this year, with new product launches and more offline distribution channels in the pipeline for the firm which specialises in organic snacks for children.
Several health and nutrition firms are showing their support for China’s fight against the deadly novel coronavirus in the form of cash, protective outfits, and nutrition products.
French organic snack company, Good Gout is expanding quickly into China’s US$14 billion children snack market through e-commerce platforms, and plans to enter Hong Kong and Singapore in September.
Health and Happiness (H&H) International Holdings Ltd has reported 11% revenue growth in the first half of 2019, from its two core business – baby nutrition and care (BNC) and adult nutrition and care (ANC).
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
